Connor, Clark & Lunn Investment Management Ltd. Adamas Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
N/A
-24,595 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
N/A
8,165 Added 49.7%
24,595 $106,000
Q3 2020

Nov 12, 2020
BUY
N/A
3,176 Added 23.96%
16,430 $68,000
Q2 2020

Aug 13, 2020
SELL
N/A
-30,712 Reduced 69.85%
13,254 $34,000
Q1 2020

May 13, 2020
BUY
N/A
20,066 Added 83.96%
43,966 $0
Q4 2019

Feb 12, 2020
BUY
N/A
23,900 New
23,900 $91,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email